|
|
|
|
Search: 
Latin American Herald Tribune
Venezuela Overview
Venezuelan Embassies & Consulates Around The World
Sites/Blogs about Venezuela
Venezuelan Newspapers
Facts about Venezuela
Venezuela Tourism
Embassies in Caracas

Colombia Overview
Colombian Embassies & Consulates Around the World
Government Links
Embassies in Bogota
Media
Sites/Blogs about Colombia
Educational Institutions

Stocks

Commodities
Crude Oil
US Gasoline Prices
Natural Gas
Gold
Silver
Copper

Euro
UK Pound
Australia Dollar
Canada Dollar
Brazil Real
Mexico Peso
India Rupee

Antigua & Barbuda
Aruba
Barbados
Cayman Islands
Cuba
Curacao
Dominica

Grenada
Haiti
Jamaica
Saint Kitts and Nevis
Saint Lucia
Saint Vincent and the Grenadines

Belize
Costa Rica
El Salvador
Honduras
Nicaragua
Panama

Bahamas
Bermuda
Mexico

Argentina
Brazil
Chile
Guyana
Paraguay
Peru
Uruguay

What's New at LAHT?
Follow Us On Facebook
Follow Us On Twitter
Most Viewed on the Web
Popular on Twitter
Receive Our Daily Headlines


  HOME | Mexico

Marijuana Oil in Mexico Proving Itself in the Campaign for Regulation

MEXICO CITY – Several creams and oils made using cannabidiol (CBD) are being publicized at the America Expoweed 2017 cannabis fair in Mexico City, at the same time that the Mexican government – for the first time – is providing treatment using cannabis-based products to 11 patients with serious illnesses such as epilepsy and cancer.

Mexican law still does not allow the sale of these products, but it does allow their import, while the Federal Protection Commission against Health Risks (Cofepris) is working on regulatory frameworks to include these types of treatments.

Last April, the Chamber of Deputies approved the medicinal use of cannabis to treat illnesses, also allowing clinical research into new treatments.

Manufacturers of the products are starting to proliferate. One of them is Cannaohm, one of the first Mexican firms to produce CBD-based products.

The firm’s director, Jiangsu Wongpec, told EFE about the different sublingual oils that will soon be available “for the public’s different illnesses and needs.”

The company will produce and distribute assorted treatments for various ailments, including oils with high concentrations of CBD and tetrahidrocannabinol (THC), another powerful psychoactive agent derived from cannabis, “for more serious diseases” such as Parkinson’s or epilepsy.

For less serious ailments, “very probably one will not need a medical prescription,” Wongpec said.

Currently, the company hopes that Colfepris “will establish the rules of the game,” although no company obtained authorization at the Expoweed fair, which runs from Aug. 18-20 in Mexico City, to physically display their products to the public.

Meanwhile, HempMeds Mexico, a subsidiary of Medical Marijuana, a US firm, was selected by the government of Mexico state to distribute oil derived from cannabis to the 11 seriously ill patients.

The oil “complies with national and international regulations for being safe and effective,” the firm said in a statement.

Meanwhile, the gradual normalization of the use of chemical derivatives of cannabis for medical purposes continues in Mexico.

 

Enter your email address to subscribe to free headlines (and great cartoons so every email has a happy ending!) from the Latin American Herald Tribune:

 

Copyright Latin American Herald Tribune - 2005-2015 © All rights reserved